The study’s small size and other weaknesses mean it does not offer a lot of helpful information in determining the possible utility of hydroxychloroquine, according to experts who reviewed the study.
Chloroquine Use For COVID-19 Shows No Benefit In First Small—But Limited—Controlled Trial
